chr10-92239705-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014912.5(CPEB3):āc.646A>Gā(p.Met216Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000638 in 1,567,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014912.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPEB3 | NM_014912.5 | c.646A>G | p.Met216Val | missense_variant | 2/10 | ENST00000265997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPEB3 | ENST00000265997.5 | c.646A>G | p.Met216Val | missense_variant | 2/10 | 1 | NM_014912.5 | ||
CPEB3 | ENST00000412050.8 | c.646A>G | p.Met216Val | missense_variant | 2/10 | 1 | P1 | ||
CPEB3 | ENST00000614585.4 | c.646A>G | p.Met216Val | missense_variant | 2/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151976Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000168 AC: 3AN: 178408Hom.: 0 AF XY: 0.0000304 AC XY: 3AN XY: 98554
GnomAD4 exome AF: 0.00000494 AC: 7AN: 1415736Hom.: 0 Cov.: 31 AF XY: 0.00000428 AC XY: 3AN XY: 700734
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152086Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.646A>G (p.M216V) alteration is located in exon 2 (coding exon 1) of the CPEB3 gene. This alteration results from a A to G substitution at nucleotide position 646, causing the methionine (M) at amino acid position 216 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at